Dusseldorf - Delayed Quote • EUR Legend Biotech Corp (9LB.DU) Folgen Add holdings 24.80 -0.40 (-1.59%) At close: May 30 at 4:00:12 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure Rückgängig Redo Alle Alle Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 9LB.DU 1 T 5 T 1 M 3 M 6 M YTD 1 J 5 J Alle Date Range 1 min Recent News: 9LB.DU Mehr anzeigen Alle News Press Releases SEC Filings Exploring High Growth Tech Stocks In The US This May 2025 Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Legend Biotech Shares Have 'Meaningful Upside' With Continued Execution, RBC Says Morning Movers: UnitedHealth sinks following CEO exit and outlook suspension Legend Biotech Corp (LEGN) Q1 2025 Earnings Call Highlights: Record Growth in CARVYKTI Sales ... Legend Biotech Reports First Quarter 2025 Results and Recent Highlights What Makes Legend Biotech (LEGN) a New Buy Stock Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results Legend Biotech Corporation (LEGN): Among Takeover Rumors Hedge Funds Are Buying Related Tickers 473A.BE Adaptimmune Therapeutics PLC 0.2400 -0.83% 6A3A.F Autolus Therapeutics plc 1.5200 +4.11% ADAP Adaptimmune Therapeutics plc 0.2925 +7.10% ALLO Allogene Therapeutics, Inc. 1.1700 -0.85% CRBU Caribou Biosciences, Inc. 1.0600 -8.62%